By Sanger sequencing we found the polymorphism in two of 128 colorectal tumors, being characterized by low CRC grading and low expression of the cell proliferation marker Ki-67, which has to be further verified in larger patient cohorts. This evidence concerns the gene MKI67 and colorectal neoplasm.